Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue
- PMID: 33034787
- DOI: 10.1007/s10565-020-09558-w
Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue
Abstract
Myopathy is the major adverse effect of statins. However, the underlying mechanism of statin-induced skeletal muscle atrophy, one of statin-induced myopathy, remains to be elucidated. Myostatin is a negative regulator of skeletal muscle mass and functions. Whether myostatin is involved in statin-induced skeletal muscle atrophy remains unknown. In this study, we uncovered that simvastatin administration increased serum myostatin levels in mice. Inhibition of myostatin with follistatin, an antagonist of myostatin, improved simvastatin-induced skeletal muscle atrophy. Simvastatin induced myostatin expression not only in skeletal muscle but also in brown adipose tissue (BAT). Mechanistically, simvastatin inhibited the phosphorylation of forkhead box protein O1 (FOXO1) in C2C12 myotubes, promoting the nuclear translocation of FOXO1 and thereby stimulating the transcription of myostatin. In differentiated brown adipocytes, simvastatin promoted myostatin expression mainly by inhibiting the expression of interferon regulatory factor 4 (IRF4). Moreover, the stimulative effect of simvastatin on myostatin expression was blunted by geranylgeranyl diphosphate (GGPP) supplementation in both myotubes and brown adipocytes, suggesting that GGPP depletion was attributed to simvastatin-induced myostatin expression. Besides, the capacities of statins on stimulating myostatin expression were positively correlated with the lipophilicity of statins. Our findings provide new insights into statin-induced skeletal muscle atrophy. Graphical headlights 1. Simvastatin induces skeletal muscle atrophy via increasing serum myostatin levels in mice; 2. Simvastatin promotes myostatin expression in both skeletal muscle and brown adipose tissue through inhibiting GGPP production; 3. The stimulating effect of statins on myostatin expression is positively correlated with the lipophilicity of statins.
Keywords: Atrophy; FOXO1; GGPP; IRF4; Myostatin; Simvastatin.
Similar articles
-
Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin.Cell Metab. 2018 Oct 2;28(4):631-643.e3. doi: 10.1016/j.cmet.2018.07.004. Epub 2018 Aug 2. Cell Metab. 2018. PMID: 30078553 Free PMC article.
-
Effects of fenofibrate and its combination with lovastatin on the expression of genes involved in skeletal muscle atrophy, including FoxO1 and its targets.J Toxicol Sci. 2021;46(1):11-24. doi: 10.2131/jts.46.11. J Toxicol Sci. 2021. PMID: 33408297
-
Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content.PLoS One. 2015 May 28;10(5):e0128398. doi: 10.1371/journal.pone.0128398. eCollection 2015. PLoS One. 2015. PMID: 26020641 Free PMC article.
-
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.Cell Mol Life Sci. 2014 Nov;71(22):4361-71. doi: 10.1007/s00018-014-1689-x. Epub 2014 Jul 31. Cell Mol Life Sci. 2014. PMID: 25080109 Free PMC article. Review.
-
PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.Curr Top Microbiol Immunol. 2010;346:267-78. doi: 10.1007/82_2010_78. Curr Top Microbiol Immunol. 2010. PMID: 20593312 Review.
Cited by
-
Is sarcopenia an associated factor of increased administration of specific medications in patients with heart failure? A systematic review and meta-analysis.Front Cardiovasc Med. 2024 Jan 25;11:1293537. doi: 10.3389/fcvm.2024.1293537. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38333416 Free PMC article. Review.
-
Endurance exercise training suppresses myostatin upregulation and nuclear factor-kappa B activation in a mouse model of Parkinson's disease.Vet World. 2022 Feb;15(2):383-389. doi: 10.14202/vetworld.2022.383-389. Epub 2022 Feb 18. Vet World. 2022. PMID: 35400955 Free PMC article.
-
Geranylgeranyl pyrophosphate depletion by statins compromises skeletal muscle insulin sensitivity.J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2697-2711. doi: 10.1002/jcsm.13061. Epub 2022 Aug 12. J Cachexia Sarcopenia Muscle. 2022. PMID: 35961942 Free PMC article.
References
-
- Ahmadi Y, Ghorbanihaghjo A, Naghi-Zadeh M, Yagin NL. Oxidative stress as a possible mechanism of statin-induced myopathy. Inflammopharmacology. 2018;26(3):667–74. https://doi.org/10.1007/s10787-018-0469-x . - DOI - PubMed
-
- Allen DL, Du M. Comparative functional analysis of the cow and mouse myostatin genes reveals novel regulatory elements in their upstream promoter regions. Comp Biochem Physiol Part B, Biochem Mol Biol. 2008;150(4):432–9. https://doi.org/10.1016/j.cbpb.2008.05.002 . - DOI
-
- Allen DL, Unterman TG. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol. 2007;292(1):C188–99. https://doi.org/10.1152/ajpcell.00542.2005 . - DOI - PubMed
-
- Barallobre-Barreiro J, Gupta SK, Zoccarato A, Kitazume-Taneike R, Fava M, Yin X, et al. Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation. Circulation. 2016;134(11):817–32. https://doi.org/10.1161/circulationaha.115.016423 . - DOI - PubMed - PMC
-
- Biesemann N, Mendler L, Wietelmann A, Hermann S, Schafers M, Kruger M, et al. Myostatin regulates energy homeostasis in the heart and prevents heart failure. Circ Res. 2014;115(2):296–310. https://doi.org/10.1161/circresaha.115.304185 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous